User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Nodular regenerative hyperplasia : a deleterious consequence of chemotherapy for colorectal liver metastases?

  1. Colina F., Alberti N., Solis J. A., Martinez-Tello F. J., Diffuse nodular regenerative hyperplasia of the liver (DNRH). A clinicopathologic study of 24 cases, 10.1111/j.1600-0676.1989.tb00409.x
  2. Nakanuma Y., J Clin Gastroenterol, 12, 460 (1990)
  3. Wanless Ian R., micronodular transpormation (nodular regenerative hyperplasia) of the liver: A report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules, 10.1002/hep.1840110512
  4. WANLESS IAN R., GODWIN THOMAS A., ALLEN FAITH, FEDER AARON, Nodular Regenerative Hyperplasia of the Liver in Hematologic Disorders : A Possible Response to Obliterative Portal Venopathy, 10.1097/00005792-198009000-00004
  5. Alison Malcolm, Golding Matthew, Lalani El-Nasir, Nagy Peter, Thorgeirsson Snorri, Sarraf Catherine, Wholesale hepatocytic differentiation in the rat from ductular oval cells, the progeny of biliary stem cells, 10.1016/s0168-8278(97)80051-7
  6. Roskams T, Baptista A, Bianchi L, Burt A, Callea F, Denk H, De Groote J, Desmet V, Hubscher S, Ishak K, MacSween R, Portmann B, Poulson H, Scheuer P, Terracciano L, Thaler H, Histopathology of portal hypertension: a practical guideline, 10.1046/j.1365-2559.2003.01464.x
  7. Molina Enrique, Reddy K. Rajender, NONCIRRHOTIC PORTAL HYPERTENSION, 10.1016/s1089-3261(05)70191-4
  8. Dachman AH, Ros PR, Goodman ZD, Olmsted WW, Ishak KG, Nodular regenerative hyperplasia of the liver: clinical and radiologic observations, 10.2214/ajr.148.4.717
  9. Stromeyer FW, Hum Pathol, 12, 60 (1981)
  10. Washington Kay, Lane Kathryn L., Meyers William C., Nodular Regenerative Hyperplasia in Partial Hepatectomy Specimens : , 10.1097/00000478-199311000-00008
  11. Rubbia-Brandt L., Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer, 10.1093/annonc/mdh095
  12. Rubbia-Brandt Laura, Mentha Gilles, Terris Benoit, Sinusoidal Obstruction Syndrome Is a Major Feature of Hepatic Lesions Associated with Oxaliplatin Neoadjuvant Chemotherapy for Liver Colorectal Metastases, 10.1016/j.jamcollsurg.2005.09.010
  13. DeLeve Laurie D., Shulman Howard M., McDonald George B., Toxic Injury to Hepatic Sinusoids: Sinusoidal Obstruction Syndrome (Veno-Occlusive Disease), 10.1055/s-2002-23204
  14. Trotter James F., Everson Gregory T., Benign Focal Lesions of the Liver, 10.1016/s1089-3261(05)70152-5
  15. Rosen AA, Am J Gastroenterol, 86, 86 (1991)
  16. Tisman Glenn, MacDonald Douglas, Shindell Neil, Reece Edward, Patel Paresh, Honda Nathan, Nishimora Earl K., Garris Joel, Shannahan William, Chisti Nadeem, McCarthy John, Nasser Moaddeli Shahriare, Sargent Dennis, Plant Ashley, Oxaliplatin Toxicity Masquerading As Recurrent Colon Cancer, 10.1200/jco.2004.99.106
  17. de Gramont A, J Clin Oncol, 18, 2938 (2000)
  18. Tournigand Christophe, André Thierry, Achille Emmanuel, Lledo Gérard, Flesh Michel, Mery-Mignard Dominique, Quinaux Emmanuel, Couteau Corinne, Buyse Marc, Ganem Gérard, Landi Bruno, Colin Philippe, Louvet Christophe, de Gramont Aimery, FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study, 10.1200/jco.2004.05.113
  19. Tournigand Christophe, Cervantes Andres, Figer Arie, Lledo Gérard, Flesch Michel, Buyse Marc, Mineur Laurent, Carola Elisabeth, Etienne Pierre-Luc, Rivera Fernando, Chirivella Isabel, Perez-Staub Nathalie, Louvet Christophe, André Thierry, Tabah-Fisch Isabelle, de Gramont Aimery, OPTIMOX1: A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer—A GERCOR Study, 10.1200/jco.2005.03.0106
  20. André Thierry, Boni Corrado, Mounedji-Boudiaf Lamia, Navarro Matilde, Tabernero Josep, Hickish Tamas, Topham Clare, Zaninelli Marta, Clingan Philip, Bridgewater John, Tabah-Fisch Isabelle, de Gramont Aimery, Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer, 10.1056/nejmoa032709
  21. Fernandez Felix G., Ritter John, Goodwin J. Wendell, Linehan David C., Hawkins William G., Strasberg Steven M., Effect of Steatohepatitis Associated with Irinotecan or Oxaliplatin Pretreatment on Resectability of Hepatic Colorectal Metastases, 10.1016/j.jamcollsurg.2005.01.024
  22. Vauthey Jean-Nicolas, Pawlik Timothy M., Ribero Dario, Wu Tsung-Teh, Zorzi Daria, Hoff Paulo M., Xiong Henry Q., Eng Cathy, Lauwers Gregory Y., Mino-Kenudson Mari, Risio Mauro, Muratore Andrea, Capussotti Lorenzo, Curley Steven A., Abdalla Eddie K., Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases, 10.1200/jco.2005.05.3074
  23. Steiner PE., Am J Pathol, 35, 943 (1959)
  24. Snover Dale C., Weisdorf Sally, Bloomer Joseph, McGlave Philip, Weisdorf Daniel, Nodular regenerative hyperplasia of the liver following bone marrow transplantation, 10.1002/hep.1840090317
  25. Abdalla E. K., Hicks M. E., Vauthey J. N., Portal vein embolization: rationale, technique and future prospects, 10.1046/j.1365-2168.2001.01658.x
  26. Di Stefano Donatella R., de Baere Thierry, Denys Alban, Hakime Antoine, Gorin Gilles, Gillet Michel, Saric Jean, Trillaud Hervé, Petit Philippe, Bartoli Jean-Michel, Elias Dominique, Delpero Jean-Robert, Preoperative Percutaneous Portal Vein Embolization: Evaluation of Adverse Events in 188 Patients, 10.1148/radiol.2342031996
Bibliographic reference Hubert, Catherine ; Sempoux, Christine ; Horsmans, Yves ; Rahier, Jacques ; Humblet, Yves ; et. al. Nodular regenerative hyperplasia : a deleterious consequence of chemotherapy for colorectal liver metastases?. In: Liver International, Vol. 27, no. 7, p. 938-943 (2007)
Permanent URL http://hdl.handle.net/2078.1/11070